DUBLIN, June 4, 2019 /PRNewswire/ -- The "Next Generation Sequencing (NGS) Market, Global Forecast by End User, Type of Test, Disease, Informatics, Reimbursement, Company Analysis, Platform, Consumable" report has been added to ResearchAndMarkets.com's offering.
The use of NGS in clinical diagnostic is one of the major factors for the future growth of NGS. Next Generation Sequencing Market is expected to surpass US$ 30 Billion by the end of the year 2025 with double digit CAGR during 2019-2025.
Next Generation Sequencing (NGS) is a recent technology in which billions of DNA strands can be sequenced through massively parallel sequencing. The Next-Generation Sequencing has revolutionized the biological study, with its ultra-high throughput, speed, and scalability; it has enabled professionals to perform a wide variety of applications and study biological systems at a level which have never been possible before.
The NGS technology is also referred to as High Throughput Sequencing. This technique minimizes the necessity for fragment-cloning methods used in Sanger sequencing of genomes. The NGS offers rapid speed, low cost, high accuracy, and accurate result even with the low sample input.
Next Generation Sequencing has the possibility to accelerate the early finding of the ailments and the recognition of pharmacogenetics markers to customize its treatments. Today, in the field of medical science, a lot of various technological advancements are going at a rapid pace and that has led to the development of a specific medicine. As a result, the development of custom made medicine has opened enormous opportunities for the application of next-generation sequencing, which could help the NGS market to grow significantly over the forecast period.
In addition; some of the major factors responsible for the growth of Next Generation Sequencing are increasing NGS application in the biological study due to its efficient advantage over traditional technologies and growing demand from the drug discovery industry. Additionally, ethical concerns associated with the whole-genome sequencing along with the lack of awareness among people are some of the factors which are expected to restrain the market growth during the forecast period.
All the companies have been analyzed from the following points: Overview, Recent Developments & Strategy
- Thermo Fisher Scientific
- Pacific Biosciences
- Oxford Nanopore Technologies
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Driver
4.1.1 Rapid Adoption of NGS in Clinical Application
4.1.2 Advancement in Next Generation Sequencing Platforms
4.1.3 Numerous Growth Factors for Next Generation Sequencing
5. Global Next Generation Sequencing (NGS) Market
6. Market Share - Global Next Generation Sequencing (NGS)
6.1 By End-User
6.2 By Type of Test
6.3 By Disease
6.4 By NGS Informatics Type
7. End-User - Global Next Generation Sequencing Market
7.1 Academic Research
8. Type of Test - Global Clinical Next Generation Sequencing Market
8.1 Targeted Re-sequencing (TPS/WES)
8.3 Whole Genome Sequencing
8.5 De Novo Sequencing
9. Disease - Global Next Generation Sequencing Test Market
9.1 Reproductive Health
9.2 Rare Disease Diagnostics
9.3 Oncology (Cancer)
9.4 Metabolic Immune (Diagnostic)
10. Platform - Global Next Generation Sequencing Market
11. Consumable - Global Next Generation Sequencing Market
12. Informatics - Global Next Generation Sequencing Market
12.1 NGS Informatics Services
12.2 Primary and Secondary Data Analysis Tools
12.5 Biological Interpretation and Reporting Tools
12.6 LIMS (Laboratory Information Management System)
14. Company Analysis
For more information about this report visit https://www.researchandmarkets.com/r/264kbs
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets